Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2026-02-06 @ 6:51 AM
Study NCT ID:
NCT04326504
Status:
RECRUITING
Last Update Posted:
2024-02-26
First Post:
2020-03-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dolutegravir and Clinical Outcomes Among ART-recipients in Brazil
Sponsor:
Organization:
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
36 Months
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: